Kathleen Laporte - 25 Mar 2024 Form 3 Insider Report for Homology Medicines, Inc. (QTTB)

Role
Director
Signature
/s/ Eric Bell, Attorney-in-Fact
Issuer symbol
QTTB
Transactions as of
25 Mar 2024
Net transactions value
$0
Form type
3
Filing time
27 Mar 2024, 17:21:03 UTC
Previous filing
16 Feb 2024
Next filing
17 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding QTTB Common Stock 5,431 25 Mar 2024 By the Kathleen LaPorte Revocable Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding QTTB Stock Option (Right to Buy) 25 Mar 2024 Common Stock 5,431 $7.29 Direct F2
holding QTTB Stock Option (Right to Buy) 25 Mar 2024 Common Stock 1,947 $7.29 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Kathleen LaPorte Revocable Trust, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose.
F2 25% of the shares underlying this option vested and became exercisable on July 19, 2022, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F3 25% of the shares underlying this option vested and became exercisable on December 17, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney